Goldline Pharmaceutical Ltd

BSE: 544759 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹33.00
Market cap: ₹31.68 Cr
Revenue (annual): ₹31.20 Cr
Net profit (annual): ₹4.12 Cr
P/E (TTM): 7.7×Sector 47.3×
Promoter holding: 57.29%
FII holding: 5.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Promoter Buying 1 Other Announcement 1 Management Change 1 Financial Results 1 Capital Structure Change 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Jul 2026 18:17 IST BSE

Management Change

Goldline Pharmaceutical Management Change

Goldline Pharmaceutical appointed M/s. Avinash Gandhewar & Associates as Secretarial Auditor for FY 2025-26. The appointment was approved during the board meeting held on July 14, 2026.

Execution: 12 months

Read the filing ↗